Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Obstetrics and Gynaecology
  • Obstetrics and Gynaecology News
  • Chemotherapy in first...

Chemotherapy in first trimester of pregnancy may highten risk of congenital anomalies: JAMA

Written By : Dr Nirali Kapoor |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2021-06-18T21:15:13+05:30  |  Updated On 18 Jun 2021 9:13 PM IST
Chemotherapy in first trimester of pregnancy may highten risk of congenital anomalies: JAMA
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Because chemotherapy attacks rapidly proliferating cells and is minimally selective, it also puts a developing fetus at risk of teratogenic effects. Toxic events during the periconceptional period might affect early embryogenesis and result in a miscarriage, whereas subsequent toxic exposure might interfere with the formation of organs, with the most susceptible period occurring between 2 and 8 weeks after conception (between 4 and 10 weeks postmenstruation). There is a wide consensus that chemotherapy should be administered until after organogenesis is completed, usually considered the first trimester of pregnancy (ie, the first 13 weeks postmenstruation).

However, the exact timing of conception might be uncertain, and some systems (eg, eyes, genitals, hematopoietic system, central nervous system) continue to develop after 10 weeks of gestation. Therefore, the question remains in clinical practice: at what exact gestational age can chemotherapy be safely initiated to avoid inducing congenital malformations?

To assess the immediate teratogenic role of prenatal chemotherapy, a cohort study carried out by Gerwen et al evaluated the presence of major and minor congenital malformations detected during pregnancy or at birth among the offspring of patients registered in the International Network of Cancer, Infertility and Pregnancy (INCIP).

The registry was started in 2005, and this cohort study was performed with a data cutoff of December 1, 2019. Patient data, including gestational age at treatment initiation, duration of chemotherapy during pregnancy, and obstetric and neonatal outcomes, were collected for all pregnant women who received chemotherapy with known obstetric outcomes. Congenital malformations were defined as structural or chromosomal malformations that were diagnosed prenatally or at birth.

In total, 755 pregnant women treated with chemotherapy between 1977 and 2019 were included in analysis. Breast cancer was the most common cancer type (59.8%), and most pregnancies ended in a live birth (99.4%). A total of 27 neonates (3.6%) were reported to have major congenital malformations, and 14 neonates (1.9%) had minor congenital malformations.

The occurrence of major congenital malformations was the highest if first chemotherapy exposure was prior to 12 weeks gestational age, at 21.7%, compared with 3.0% congenital malformations among offspring of women who began chemotherapy after 12 weeks gestation, with the greatest risk for women who began chemotherapy periconceptionally.

The occurrence of major malformations when chemotherapy was initiated after 12 weeks of gestation was lower and remained stable with advanced pregnancy. The occurrence of minor malformations was comparable with the rates expected in the general population when exposure occurred prior or after 12 weeks gestational age.

A total of 29 women initiated chemotherapy prior to 12 weeks of gestation. In 17 women (58.6%), pregnancy status was not known at the moment of chemotherapy initiation. A total of 6 patients (20.7%, all with hematological malignant neoplasms) experienced an early miscarriage after chemotherapy (3 women [10.3%]) or opted to terminate the pregnancy for oncological reasons (3 women [10.3%]). Of the remaining 23 neonates prenatally exposed to chemotherapy prior to 12 weeks of gestation, 6 (26.1%) had congenital malformations.

The study found an association between chemotherapy before 12 weeks of gestation and increased risk of congenital malformations detected during pregnancy or at birth. The overall congenital malformation rate among offspring of mothers who initiated chemotherapy after 12 weeks of gestation was 4.8%, which is comparable to the expected rates in the general population (ie, 2.5%-6.9% for major malformations and 6.5%-35.8% for minor malformations).

First-trimester chemotherapy exposure has been associated with 10% to 20% risk of major malformations. Mechanisms by which chemotherapeutics induce teratogenic effects are incompletely understood. To date, the reported malformations after oncological treatment during human pregnancy encompass all organ systems, without discernible pattern for most cytotoxic drugs, except for aminopterin and methotrexate. The nature of teratogenesis is extremely complex; individual genetic susceptibility, specific timing of cytotoxic exposure, and specific type of (co-)medication all determine the spectrum of anomalies.

Data on the risks of congenital malformations are indispensable for clinicians and patients when considering chemotherapy during pregnancy. Based on these findings, the authors suggest that when cancer is diagnosed in early pregnancy, chemotherapy can be initiated from 12 weeks onward.

Therefore, accurate ultrasonographic dating is crucial. The introduction of a 1-week safety period could be considered to further minimize the risk of chemotherapy-induced congenital malformations. However, no rationale exists to delay the start of chemotherapy beyond 14 weeks of gestation, as recommended previously. If a patient desires certainty on risk of chromosomal anomalies, an amniocentesis for karyotyping and microarray could be offered, since noninvasive prenatal testing is not conclusive in patients with cancer owing to tumor cell-free DNA interference.

These findings suggest that chemotherapy during the first 12 weeks of pregnancy was associated with increased risk for congenital malformations in the fetus. If an aggressive cancer diagnosis during early pregnancy does not allow treatment delay, parents should be counseled on fetal risks of malformations. If a patient incidentally becomes pregnant while receiving chemotherapy, prenatal counselling should include the risks of both short- and long-term adverse outcomes. Adequate anticonception and routine pregnancy tests should be offered to fertile women with cancer.

Source: Gerwen et al; JAMA Network Open. 2021;4(6):e2113180.

doi:10.1001/jamanetworkopen.2021.13180


chemotherapycongenital malformationsfirst trimester pregnancy
Source : JAMA Network Open
Dr Nirali Kapoor
Dr Nirali Kapoor

    MBBS, MD Obstetrics and Gynecology

    Dr Nirali Kapoor has completed her MBBS from GMC Jamnagar and MD Obstetrics and Gynecology from AIIMS Rishikesh. She underwent training in trauma/emergency medicine non academic residency in AIIMS Delhi for an year after her MBBS. Post her MD, she has joined in a Multispeciality hospital in Amritsar. She is actively involved in cases concerning fetal medicine, infertility and minimal invasive procedures as well as research activities involved around the fields of interest.

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    View All

    Journal Club Today

    Global Omega-3 Shortage Poses Serious Health and Environmental Risks: Study

    Global Omega-3 Shortage Poses Serious Health and Environmental Risks: Study

    View All

    Health News Today

    Health Bulletin 30/May/2025

    Health Bulletin 30/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok